Neurogen Corp (NASDAQ:NRGN)

CAPS Rating:

A drug discovery & development company focusing on new small molecule drugs to improve the lives of patients suffering from disorders with unmet medical need including insomnia, obesity, pain, Parkinson's disease, Restless Legs Syndrome & depression.